Fundraising Fox

Microbot Medical Inc.

NASDAQ: MBOT

Braintree, US · Delaware corporation · 1 known investors

BiotechHealthtech

Founders & leadership

HG
Harel GadotExecutive Officer, Director
RV
Rachel VakninExecutive Officer
SS
SIMON SHARONExecutive Officer
JD
Juan Diaz-CartelleExecutive Officer
MS
Moshe ShohamDirector
YW
Yoav WaizerDirector
DB
David Ben NaimChief Financial Officer
YB
Yoseph BornsteinDirector
YH
Yehezkel HimelfarbChief Operating Officer
SM
Solomon MayerDirector
AS
Aileen StockburgerDirector
TW
Tal WenderowDirector

Investors · 1

Star51 CapitalreportedNew York

Reported raises · per SEC filings

Form D private placements
▶$25.2MraisedSep 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aileen StockburgerDirector
  • Martin MaddenDirector
  • Rachel VakninExecutive Officer
  • Tal WenderowDirector
  • HAREL GADOTExecutive Officer, Director
  • Prattipati LaxminarainDirector
  • Juan Diaz- CartelleExecutive Officer
  • David WilsonDirector
  • SIMON SHARONExecutive Officer
  • Scott BurellDirector
Offering amount
$25.2M
Amount sold
$25.2M
Sales commissions
$2.1M
Placement agents
H.C. WAINWRIGHT & CO., LLC
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13MraisedFeb 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott BurellDirector
  • Tal WenderowDirector
  • Aileen StockburgerDirector
  • Juan Diaz- CartelleExecutive Officer
  • Martin MaddenDirector
  • David WilsonDirector
  • Rachel VakninExecutive Officer
  • SIMON SHARONExecutive Officer
  • HAREL GADOTExecutive Officer, Director
  • Prattipati LaxminarainDirector
Offering amount
$13M
Amount sold
$13M
Sales commissions
$1M
Placement agents
H.C. Wainwright & Co.
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.6MraisedJan 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aileen StockburgerDirector
  • Tal WenderowDirector
  • HAREL GADOTExecutive Officer, Director
  • Prattipati LaxminarainDirector
  • Rachel VakninExecutive Officer
  • Scott BurellDirector
  • SIMON SHARONExecutive Officer
  • Martin MaddenDirector
  • David WilsonDirector
  • Juan Diaz-CartelleExecutive Officer
Offering amount
$8.6M
Amount sold
$8.6M
Sales commissions
$688K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedJan 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rachel VakninExecutive Officer
  • Scott BurellDirector
  • HAREL GADOTExecutive Officer, Director
  • Martin MaddenDirector
  • Juan Diaz-CartelleExecutive Officer
  • SIMON SHARONExecutive Officer
  • Prattipati LaxminarainDirector
  • Aileen StockburgerDirector
  • David WilsonDirector
  • Tal WenderowDirector
Offering amount
$7M
Amount sold
$7M
Sales commissions
$560K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedJun 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aileen StockburgerDirector
  • Martin J. MaddenDirector
  • Yoseph BornsteinDirector
  • Tal WenderowDirector
  • Simon SharonExecutive Officer
  • Rachel VakninExecutive Officer
  • Scott BurellDirector
  • Juan Diaz-CartelleExecutive Officer
  • Harel GadotExecutive Officer, Director
  • Prattipati LaxminarainDirector
Offering amount
$1.8M
Amount sold
$1.8M
Sales commissions
$164.5K
Placement agents
H.C. Wainwright & Co.
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJan 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Harel GadotExecutive Officer, Director
  • David Ben NaimExecutive Officer
  • Yoav WaizerDirector
  • Pratipatti LaxminarainDirector
  • Scott BurellDirector
  • Martin MaddenDirector
  • Yoseph BornsteinDirector
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJan 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Ben NaimExecutive Officer
  • Martin MaddenDirector
  • Scott BurellDirector
  • Harel GadotExecutive Officer, Director
  • Yoav WaizerDirector
  • Yoseph BornsteinDirector
  • Pratipatti LaxminarainDirector
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJan 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Ben NaimExecutive Officer
  • Yoav WaizerDirector
  • Yoseph BornsteinDirector
  • Pratipatti LaxminarainDirector
  • Scott BurellDirector
  • Martin MaddenDirector
  • Harel GadotExecutive Officer, Director
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.